Viatris Inc (NASDAQ:VTRS)

8.71
Delayed Data
As of Sep 23
 -0.23 / -2.57%
Today’s Change
8.43
Today|||52-Week Range
15.60
-35.62%
Year-to-Date
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Sep 23 / Zacks.com - Paid Partner Content
Is Viatris Stock a Buy Now?
Sep 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close8.94
Today’s open8.87
Day’s range8.44 - 8.87
Volume653,342
Average volume (3 months)10,948,282
Market cap$11.6B
Data as of 4:00pm ET, 09/23/2022

Growth & Valuation

Earnings growth (last year)+5.78%
Earnings growth (this year)-7.75%
Earnings growth (next 5 years)-1.88%
Revenue growth (last year)+49.53%
P/E ratio13.8
Price/Sales0.92
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
BHVNBiohaven Pharmaceuti...+0.59+0.39%
RGENRepligen Corp-8.70-4.58%
SRPTSarepta Therapeutics...-2.66-2.40%
UTHRUnited Therapeutics ...-0.30-0.14%
Data as of 4:00pm ET, 09/23/2022

Financials

Next reporting dateNovember 7, 2022
EPS forecast (this quarter)$0.84
Annual revenue (last year)$17.9B
Annual profit (last year)-$1.3B
Net profit margin-7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Canonsburg, Pennsylvania

Forecasts